eureKARE seeks disruptive synthetic biology solutions to tackle environmental and sustainability challenges
03. Juli 2023 08:37 ET
|
EUREKARE
The 2nd edition of the eurekAWARDS is launched! Luxembourg, Belgium, Monaco, and Paris, France – 3 July 2023: eureKARE, a pioneering company focused on financing and building next generation...
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
30. Mai 2023 16:06 ET
|
EUREKARE
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de...
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader
30. Mai 2023 16:06 ET
|
EUREKARE
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company’s unique offer...
eureKING, le premier SPAC européen dans la santé dédié à la bioproduction, annonce son intention de se rapprocher de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
16. Mai 2023 11:45 ET
|
EUREKARE
Skyepharma, un CDMO (« Contract Development Manufacturing Organisation ») basé en France avec plus de 20 ans d'expertise en matière d'innovation et de développement, est un acteur reconnu dans les...
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces its intention to combine with Skyepharma to build a new European bio-CDMO leader
16. Mai 2023 11:45 ET
|
EUREKARE
Skyepharma, a France-based CDMO with over 20 years of innovation and development expertise, is a renowned player in the global biopharma and consumer health industries. The company’s unique offer in...
eureKARE co-founds EonBio to revolutionize drug discovery with pioneering cell-free technology on a chip
22. Februar 2023 04:03 ET
|
eureKARE
eureKARE co-founds EonBio to revolutionize drug discovery with pioneering cell-free technology on a chip eureKARE announces EonBio as the second company to be supported by its Belgium biomedical...
eureKARE appoints Anne Lauvergeon as a new Board member
08. Februar 2023 05:39 ET
|
eureKARE
eureKARE appoints Anne Lauvergeon as a new Board member Luxembourg, Belgium, and Paris, France – 8 February 2023: eureKARE, an innovative investment company for disruptive synthetic biology...
eureKARE welcomes Dirac Biosciences as first company into its biomedical start-up studio
01. Februar 2023 02:00 ET
|
eureKARE
eureKARE welcomes Dirac Biosciences as first company into its biomedical start-up studio Innovative gene circuit technology has the potential to detect and treat cancerous and other diseased cells ...
eureKARE co-leads EUR 5 million seed investment in Biomemory which is advancing cutting-edge DNA-based data storage solutions
28. November 2022 02:00 ET
|
eureKARE
eureKARE co-leads EUR 5 million seed investment in Biomemory which is advancing cutting-edge DNA-based data storage solutions Luxembourg, Belgium, and Paris, France – 28 November 2022: eureKARE...
eureKARE launches innovation-driven start-up studio in Monaco to apply synthetic biology in tackling critical environmental challenges
15. November 2022 02:00 ET
|
eureKARE
eureKARE launches innovation-driven start-up studio in Monaco to apply synthetic biology in tackling critical environmental challenges Luxembourg, Belgium, and Paris, France – 15 November...